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Background. The molecular mechanisms linking abnormal
kidney function and obesity hypertension are poorly under-
stood. This study compared gene expression profiles in the kid-
ney medulla and cortex of obese and lean dogs.
Methods. Lean dogs (N = 4) were fed a standard kennel ra-
tion and obese dogs (N = 4) were fed the standard diet plus
0.5 to 0.9 kg of cooked beef fat per day for 10 weeks. The dogs
were instrumented for continuous monitoring of mean arterial
pressure (MAP), heart rate, glomerular filtration rate (GFR),
and effective renal plasma flow (RPF). The relative mRNA lev-
els of 375 genes in renal cortex and medulla were determined
simultaneously using cDNA membrane arrays (R&D Systems).
Results. The high fat diet increased body weight by 57% and
MAP increased by 24 mm Hg (112 ± 1 mm Hg vs. 88 ± 3 mm Hg)
in obese compared to lean dogs. In obese dogs, expression of 11
and 13 genes changed significantly (N = 4; P < 0.05) in the renal
medulla and the cortex, respectively, relative to the lean dogs.
Differences in renal gene expression profiles between lean and
obese dogs were closely related to functional pathways, includ-
ing those associated with sympathetic activation, inflammatory
response, matrix formation, angiogenesis, endothelial dysfunc-
tion, attenuated actions of leptin, and attenuated cell survival.
Conclusion. A high fat diet in dogs is associated with marked
changes in renal gene expression profiles that provide poten-
tial molecular links to pathways associated with altered renal
function and structure in obesity hypertension.
Obesity affects more than one third of American adults
[1] and causes multiple target organ injury [2]. Some
pathologic consequences of obesity include hyperten-
sion, type 2 diabetes, hyperlipidemia, hypercoagulation,
stroke, and renal disease [2]. Epidemiologic studies sug-
gest that more than 50% of the risk for human essential
hypertension cases is related to obesity [3]. Studies in
animals and humans show that weight gain raises blood
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pressure and that weight loss reduces blood pressure in
both normotensive and hypertensive subjects [4–6]. Obe-
sity may also be an important risk factor for renal disease,
not only through its effects to cause hypertension and
type II diabetes, but also through additional mechanisms
that are poorly understood [7].
Although the mechanisms of obesity-associated hyper-
tension are complex and multifactorial, increased renal
tubular reabsorption and a hypertensive shift of pressure
natriuresis play a key role in raising arterial pressure [7].
Obesity enhances renal tubular reabsorption by increas-
ing renal sympathetic nerve activity, activating the renin-
angiotensin system (RAS), and by physical compression
of the kidneys [7]. Our previous studies suggest that obe-
sity increases renal extracellular matrix (ECM) forma-
tion in the renal medulla and in glomeruli, and that these
changes may contribute to a hypertensive shift of pres-
sure natriuresis [8]. We found that dogs fed a high fat diet
for 7 to 9 weeks or 24 weeks exhibited early changes in
renal structure and function [9]. These changes include
increased glomerular filtration rate (GFR) and renal
plasma flow (RPF), elevated arterial blood pressure, ex-
pansion of Bowman’s capsule, increased cell proliferation
in the glomerulus, and thickening of the mesangial ma-
trix and Bowman’s capsule basement membranes. How-
ever, there are no studies, to our knowledge, that have
examined the changes in renal gene expression that may
be involved in the pathophysiology of obesity-associated
hypertension and renal disease.
The present study examined potential molecular links
between obesity hypertension and abnormal kidney func-
tion by comparing gene expression profiles in kidney
cortex and medulla of lean dogs (fed the standard diet)
and obese dogs (fed a high fat diet). We also examined
changes in mean arterial pressure (MAP) and renal func-
tion associated with obesity induced by feeding a high
fat diet in dogs, a model that that closely mimics cardio-
vascular, renal, endocrine, and metabolic changes that
occur in obese humans [5]. Moreover, obesity has been
shown to be a proinflammatroy state in animal models
and humans. Thus, we focused on cytokines in the present
study. Cytokine cDNA membrane arrays containing 375
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cytokine-related genes and 9 housekeeping genes were
used to compare renal gene expression profiles in obese
and lean dogs. In addition, a reliable data analysis method
was developed based on the normalization of gene ex-
pression data by stable internal housekeeping genes.
METHODS
Animal protocol
The protocols were carried out according to the guide-
lines for the care and use of laboratory animals imple-
mented by the National Institutes of Health and the
Guidelines of the Animal Welfare Act and were approved
by the University of Mississippi Medical Center Institu-
tional Animal Care and Use Committee. We used eight
conditioned male mongrel dogs in this experiment. Four
dogs became obese after 10 weeks of being fed the high fat
diet, which included an additional 0.5 to 0.9 kg of cooked
beef per day added to the regular diet (standard kennel
ration). Four control lean dogs were fed the same stan-
dard kennel ration but were not given the beef fat sup-
plement. Total sodium intake, including sodium in the
food and intravenous saline infusions, was maintained
constantly at approximately 76 mmol/day for both groups
of dogs.
Physiologic measurements
Surgical procedures were performed on dogs during
isoflurane anesthesia, using aseptic techniques. Tygon
(Norton Plastics, Akron, OH, USA) catheters were im-
planted into the femoral arteries and veins for mea-
surement of arterial blood pressure and blood sampling,
respectively. After a recovery period of 1 to 2 weeks,
the dogs were housed in individual metabolic cages and
instrumented for continuous monitoring of MAP, heart
rate, GFR, and effective RPF, as previously described [5].
Plasma renin activity, plasma sodium concentration, and
plasma potassium concentration were also determined as
previously described [5].
RNA isolation
Kidney tissues of the cortex and medulla were immedi-
ately dissected and frozen for total RNA preparation us-
ing a modified guanidinium-based method (Totally RNA
Isolation Kit) (Ambion, Austin, TX, USA), as previ-
ously described [10]. The genomic DNA was removed by
treating with Rnase-free Dnase I for 45 minutes at 37◦C
followed by phenol/chloroform extraction and ethanol
precipitation. Absence of genomic DNA contamination
was determined by polymerase chain reaction (PCR) am-
plification of the actin gene. RNA integrity was verified
on a 3-[N-morpholine] propane sulfonic acid (MOPS)-
formaldehyde agarose gel prior to cDNA synthesis. The
RNA sample had an A260/A280 ratio of 1.8 or above.
Obese
Lean
Fig. 1. The membrane images of expression profile arrays of 375
cytokine-related genes plus nine housekeeping genes in the kidney
medulla of obese and lean dogs after 10 weeks of a diet program. Known
genes (cDNA fragments) are immobilized in duplicate on a nylon mem-
brane that is hybridized to a 32P-labeled cDNA probe representing ex-
pressed genes in a particular tissue. The tetrad positive control spots
at the four corners in both membranes are similar with minimal back-
ground noise around the gene spots, which indicate that the membranes
have undergone thorough hybridization and washes. Quantitation of
gene expression signals was performed on membrane images of dupli-
cate spots representing each gene using a Phosphor-Imager (Molecular
Dynamics, Eugene, OR, USA).
cDNA labeling and membrane-array hybridization
The cDNA array hybridization technique relies on
the principle of reverse Northern blotting. Known genes
(cDNA fragments) are immobilized in duplicate on a ny-
lon membrane that is hybridized to a 32P-labeled cDNA
probe [generated by reverse transcription (RT)] repre-
senting expressed genes in a particular tissue. Human
cDNA expression arrays were obtained from R&D Sys-
tems (Minneapolis, MN, USA) and all procedures were
followed as recommended by the manufacturer’s proto-
cols. We utilized a step-by-step intensive wash method to
minimize the background noise. After stringent washing,
membranes were exposed to a phosphor screen (Molecu-
lar Dynamics, Eugene, OR, USA) (software ImageQuant
3.3) for 4 or 24 hours. Analysis was conducted after 4 or
24 hours of exposure not only to ensure that hybridization
intensity was in the linear range, but also to collect data
(signal intensity) on genes with low expression levels.
Analysis of array data
We analyzed the cDNA array membrane with minimal
background noise. For example, Figure 1 shows the im-
ages of expression profile arrays of 375 cytokine-related













Fig. 2. The relative densitometric units of ribosome protein L19
mRNA in the renal medulla of lean dogs were very similar to those
observed in obese dogs (100 vs. 99.16; P = 0.8116; N = 4). Analyzing
the four sets of hybridization (one lean and one obese membrane for
each set) for the renal medulla or cortex tissue, the data indicated that
ribosome protein L19 mRNA was the most stable gene signal among
the nine housekeeping genes and did not change between lean and
obese groups. Therefore, L19 mRNA signal was chosen as the internal
housekeeping gene to normalize the signals of all genes in each set of
arrays.
genes in the kidney medulla of obese and lean dogs.
Quantitation of gene expression signals was performed
on membrane images of duplicate spots representing
each gene using a Phosphor-Imager (Molecular Dynam-
ics). Raw values of pixel intensity were extracted from
membrane-array images using the software ImageQuant
3.3 (Molecular Dynamics). This yielded values for the
mean signal intensity, which were adjusted by the local
background area (same size as the spot area). The mean of
their signal intensities and their standard deviation were
calculated. A spot was defined as “nondetectable” if its
mean signal intensity was less than the mean of the neg-
ative control signal intensities plus two times the nega-
tive control standard deviation for that same membrane.
There were nine listed housekeeping genes in each array.
By analyzing the four sets of hybridization (one lean and
one obese membrane for each set) for the renal medulla
or cortex tissue, the data indicated that ribosome protein
L19 mRNA was the most stable gene signal among the
nine housekeeping genes and did not change between
lean and obese groups (Fig. 2). We also found that the
relative densitometric units of the ribosome protein L19
signal in both renal medulla of lean vs. obese dogs or re-
nal cortex of lean vs. obese dogs were very similar (99.2 ±
3.4 and 99.0 ± 2.9, respectively, compared to normalized
ratios of 100 for medulla and cortex of lean dogs). The rel-
ative signal of the mRNA expression was defined as the
densitometric ratio of gene-specific mRNA signal inten-
sity over a housekeeping gene known as ribosome protein
L19. The next step in data analysis was to compare the
normalized signals (relative mRNA levels) on different
arrays to identify expressed genes that were statistically
different between two groups, lean and obese (N = 4).
Statistical significance was defined as a two-tail Student
t test value of P < 0.05. Unpaired Student t test was used
to make comparisons between the two groups.
Northern blotting
Expression of vascular endothelial growth factor
(VEGF) or transforming growth factor-b1 (TGF-b1)
mRNA in the renal medulla tissues of obese and lean dogs
was further examined by Northern blotting. The same
total RNA samples were used for Northern blot analy-
ses that were used in previously described methods [10].
The VEGF cDNA probe was a 580 bp EcoRI-BamHI
fragment of the murine VEGF cDNA that could have a
cross-reaction with dog VEGF sequence [11]. The TGF-
b1 cDNA probe was a 1.05 kb EcoRI-EcoRI fragment
of human TGF-b1 cDNA that was cloned into pSP64
palsmid [12]. The VEGF mRNA or TGF-b1 expression
was normalized against 28S rRNA in each sample.
Statistical analyses
All determinations were performed in duplicate. Data
was presented as mean ± SE, as indicated. Differences
were considered statistically significant when P < 0.05
by paired or unpaired t test. All statistical calculations
were performed with StatView software (BrainPower,
Calabasa, CA, USA). Control hemodynamic and renal
function data obtained for dogs before initiation of the
high fat diet period were compared with data obtained
for the same dogs after the high fat diet period by using
ANOVA and Dunnett’s t test for multiple comparison
[9].
RESULTS
Weight, hemodynamic, renal function, and
hormonal data
Table 1 summarizes weight, hemodynamic, renal func-
tion, and hormonal data for dogs fed a high fat diet (obese
group) or standard diet (control group) for 10 weeks.
Body weight in obese dogs was 57% greater than in lean
dogs. Kidney weight was increased by an average of 46%
in dogs fed a high fat diet for 10 weeks, compared to dogs
fed a standard diet. MAP was increased by 24 mm Hg
(112 ± 1 mm Hg vs. 88 ± 3 mm Hg) in obese dogs com-
pared to lean dogs (P < 0.05). Heart rate averaged 119 ±
2 beats/min and 69 ± 2 beats/min in obese and lean dogs,
respectively. GFR and effective RPF were 71% and 58%
greater, respectively, in obese dogs compared with lean
dogs. There were no significant differences in plasma con-
centrations of sodium and potassium in obese dogs com-
pared with lean dogs. Plasma renin activity was 1.8-fold
higher in the obese group, compared to the control group.
716 Gu et al: Differential renal gene expression profiles in obese and lean dogs
Table 1. Weight, hemodynamics, renal function, and hormonal data
for obese and lean dogsa
Lean Obese
Parameter (N = 4) (N = 4)
Body weight kg 19.4 ± 1.6 30.4 ± 1.9b
Kidney weight g 41.9 ± 2.5 61.2 ± 3.1b
Mean arterial pressure mm Hg 88 ± 3 112 ± 1b
Heart rate beats/min 69 ± 2 119 ± 2b
Glomerular filtration rate 68 ± 3 117 ± 5b
mL/min
Effective renal plasma flow 166 ± 15 264 ± 17b
mL/mL
Plasma sodium concentration 149 ± 0.4 148 ± 0.5
mEq/mL
Plasma potassium concentration 4.27 ± 0.1 4.04 ± 0.03
mEq/mL
Plasma renin activity 0.36 ± 0.10 0.63 ± 0.05b
ng angiotensin I/mL per min
aData are means ± SEM; bP < 0.05 versus lean.
Cytokine gene expression profiles in the renal medulla
of obese and lean dogs
Figure 1 shows the images of expression profile ar-
rays of 375 cytokine-related genes plus nine housekeep-
ing genes in kidney medulla of obese and lean dogs
after 10 weeks of a diet program. A complete list of
genes contained in the array can be accessed at the web
site (www.rndsystems.com). We divided the genes into
groups:(1) adhesion molecules (22 genes); (2) angiogenic
factors and their receptors (32 genes); (3) cell surface
proteins (19 genes); (4) chemokines and their recep-
tors (48 genes); (5) cytokines, cytokine receptors, and
nitric oxide–related factors (57 genes); (6) binding pro-
teins and integrins (27 genes); (7) epidermal growth fac-
tor (EGF) and TGF family (30 genes); (8) ephrins and
their receptors (16 genes); (9) interleukins (IL) and their
receptors (40 genes); (10) neurotrophic factors and or-
phan receptors (32 genes); (11) protease or related fac-
tors (21 genes); (12) tumor necrosis factor (TNF) family
(31 genes); and (13) housekeeping genes (9 genes).
As previously mentioned, expression of a gene to
abundance of mRNA transcripts was defined as “non-
detectable” if its mean signal intensity was less than
the mean of the negative control signal intensities plus
two times the negative control standard deviation. Using
these criteria, all genes indicated above were detectable
in the renal medulla of obese and lean dogs.
Table 2 shows that expressed relative mRNA levels
of 11 renal medullary genes were significantly changed
among the 375 genes expressed in lean and obese dogs
(N = 4, P < 0.05). In obese dogs, up-regulation occurred
in 10 genes: endothelin-3 (61%, P = 0.012), fibroblast
growth factor-14 (FGF-14) (68%, P = 0.033), glial cell
line–derived neurotrophic factor receptor-a3 (GFR-a3)
(47%, P = 0.002), STRL-33 (a member of the chemokine
receptor family) (95%, P = 0.040), TGF-a (98%, P =
0.037), TGF-b1 (60%, P = 0.028), VEGF-B (37%, P =
Table 2. Significantly altered expression of renal medullary genes
between obese and lean dogs
Relative mRNA levels (mean ± SE)
Genesa Lean Obese % Change P valueb
FGR-14 0.24 ± 0.030 0.41 ± 0.060 + 68 0.033
Endothelin-3 0.86 ± 0.130 1.40 ± 0.025 + 61 0.012
GFR-a3 0.91 ± 0.075 1.35 ± 0.055 + 47 0.002
STRL33 0.03 ± 0.005 0.07 ± 0.010 + 95 0.040
IL-13Ra2 0.37 ± 0.065 0.57 ± 0.075 + 52 0.049
P-selectin 0.07 ± 0.005 0.10 ± 0.010 + 45 0.029
ENA-78 1.56 ± 0.135 1.04 ± 0.120 + 49 0.016
MMP-3 .029 ± 0.007 .007 ± 0.005 −72 0.045
TGF-b1 0.03 ± 0.005 0.09 ± 0.011 + 60 0.028
TGF-a 0.75 ± 0.265 1.48 ± 0.195 + 98 0.037
VEGF-B 1.08 ± 0.140 1.48 ± 0.050 + 37 0.032
Abbreviations are: FGF-14, fibroblast growth factor-14; GFR-a3, glial
cell line–derived neurotrophic factor receptor-a3; IL-13Ra2, interleukin-13
receptor-a2; ENA-78, epithelial cell–derived neutrophil attractant-78; MMP-3,
matix metalloproteinase-3; TGF-b1 and -a, transforming growth factor-b1 and
-a; VEGF-B, vascular endothelial growth factor-B. aSee Results section for more
detailed gene descriptions; bThe statistical significance was defined as a two-tail
Student t-test value of P < 0.05 (N = 4).
0.032), P-selectin (45%, P = 0.029), epithelial cell–
derived neutrophil attractant-78 (ENA-78) (49%, P =
0.016), and IL-13 receptor-a2 (IL-13Ra2) (52%, P =
0.049). Matrix metalloproteinase-3 (MMP-3) mRNA ex-
pression was down-regulated by 72% (P = 0.049) in the
obese dogs compared with the lean control dogs.
Northern blot analysis TGF-b1 and VEGF mRNA
expression in renal medulla of obese and lean dogs
The expressions of TGF-b1 and VEGF mRNA in
the kidney medulla of obese and lean dogs were also
determined by Northern blot analysis. We found that
the expressions of TGF-b1 increased by 74% in the
kidney medulla of obese dogs, compared to lean dogs
(P < 0.01; N = 4) (Fig. 3). This result was consistent with
the data resulted from cDNA membrane array analysis
in which TGF-b1 mRNA expression increased by 60%
in obese dogs, compared to lean dogs. We used a 580 bp
EcoR1-BamH1 fragment of a murine VEGF cDNA
probe for Northern blot analysis. In our previous study
[11], this VEGF probe was successfully used to deter-
mine VEGF mRNA expression in cultured dog coronary
artery smooth muscle cells. Figure 3 indicates that VEGF
mRNA expression increased by 1.9-fold in the kidney
medulla obese compared to lean dogs (N = 4, P < 0.01).
In the cDNA membrane array analysis, VEGF-B mRNA
increased 1.4-fold in the renal medulla of obese compared
to lean dogs.
Cytokine gene expression profiles in the renal cortex
of obese and lean dogs
Using the threshold as described in the Methods sec-
tion, we found that only 4 of 375 genes had nondetectable
spots on the array membrane while analyzing the renal


































Fig. 3. Northern blot analysis of transform-
ing growth factor-b1 (TGF-b1) (A) or vas-
cular endothelial growth factor (VEGF) (B)
mRNA expression in the kidney medulla of
obese dogs compared to the lean dogs. To ver-
ify the relative amounts of total RNA, filters
were hybridized with a 32P-labeled 28S rTNA
antisense oligonucleotide probe (Ambion).
The relative mRNA expression of TGF-b1
increased by 74% in the kidney medulla of
obese dogs, compared to lean dogs (P < 0.01;
N = 4). The relative mRNA of VEGF in-
creased by 1.9-fold in the kidney medulla of
obese dogs compared to the lean dogs (P <
0.01, N = 4).
Table 3. Significantly altered expression of renal cortex genes
between obese and lean dogs
Relative mRNA levels (mean ± SE)
Genesa Lean Obese % Changes P valueb
Leptin R .007 ± 0.001 .002 ± 0.001 −76 0.022
LIFR .012 ± 0.004 .002 ± 0.001 −87 0.026
TIMP-3 0.25 ± 0.015 0.15 ± 0.020 −38 0.006
Ephrin-A1 0.06 ± 0.004 0.10 ± 0.015 +40 0.042
FGF-1 0.02 ± 0.003 0.01 ± 0.004 −46 0.044
FGF-3 .074 ± 0.004 .047 ± 0.007 −36 0.006
CTGF 0.09 ± 0.010 0.05 ± 0.010 −43 0.020
Integrin-a 3 1.40 ± 0.121 0.92 ± 0.111 −34 0.013
MIP-1d 0.05 ± 0.010 0.02 ± 0.005 −56 0.018
BCA-1 0.01 ± 0.001 .007 ± 0.001 −32 0.033
OSM-Rb 0.06 ± 0.008 0.04 ± 0.004 −34 0.041
VCAM-1 0.01 ± 0.004 .004 ± 0.001 −67 0.046
K-cadherin 0.03 ± 0.004 .012 ± 0.002 −55 0.008
Abbreviations are: LIFR, leukemia inhibitory factor receptor; TIMP-3, tissue
inhibitor of metalloproteinase-3; FGF-1 and -3, fibroblast growth factor-1 and
-3; CTGF, connective tissue growth factor; MIP-1d, macrophage inflammatory
protein-1d; BCA-1, B-cell–attracting chemokine-1; OSM-Rb , oncostatin M
receptor b ; VCAM-1, vascular cell adhesion molecule-1.
aSee Results section for more detailed gene description; bthe statistical
significance was defined as a two-tail Student t test value of P < 0.05 (N = 4).
cortex gene profiles of obese and lean dogs. These genes
included leptin, C-kit ligand, monocyte chemoattractant
protein-2 (MCP-2), and IL-8. In analyzing four sets of
hybridizations (one lean and one obese membrane for
each set) for the cortex, the data also indicated that ri-
bosome protein L19 mRNA was the most stable gene
among the nine housekeeping genes listed. The relative
densitometric units of ribosome protein L19 mRNA in
the cortex were shown not to change between lean and
obese groups (100 ± 0.0 vs. 99.0 ± 2.9; P = 0.8023; N =
4). Thus, we also used the ribosome L19 protein mRNA
signal as the housekeeping gene to normalize signals of
all the genes in each set of renal cortex arrays.
Table 3 indicates that expressed relative mRNA lev-
els of 13 renal cortex genes were significantly different
between lean and obese dogs among the 375 genes ex-
amined (N = 4, P < 0.05). The expression of ephrin-
A1 mRNA increased by 40% (P = 0.042) in the kidney
cortex of obese compared to lean dogs. In obese dogs,
the 12 genes that were down-regulated included leptin
receptor (76%, P = 0.022), leukemia inhibitory factor
receptor (LIFR) (87%, P = 0.026), tissue inhibitor of
metalloproteinase-3 (TIMP-3) (38%, P = 0.006), onco-
statin M receptor b (OSM-Rb) (34%, P = 0.041), FGF-1
(46%, P =0.044), FGF-3 (36%, P =0.006), connective tis-
sue growth factor (CTGF) (43%, P = 0.020), integrin-a3
(34%, P = 0.013), K cadherin (55%, P = 0.008), vascular
cell adhesion modecule-1 (VCAM-1) (67%, P = 0.046),
B-cell–attracting chemokine (BCA-1) (32%, P = 0.033),
and macrophage inflammatory protein-1d (MIP-1d)
(56%, P = 0.018).
Comparison of different gene expression patterns
between renal medulla and cortex
We compared the expression profiles between the re-
nal medulla and cortex in lean dogs (control group),
as indicated in Table 4. Of the 375 genes in the array,
there were 89 (24%) genes with significantly different
(P < 0.05) expression in the renal medulla compared
to the cortex. Seventy-one of the 89 genes were up-
regulated and the other 18 genes were down-regulated
in the medulla compared to the cortex. Some genes were
highly expressed in the medulla compared to the cortex
and some genes were highly expressed in the cortex com-
pared to the medulla. For example, the relative mRNA
level of interferon (IFN)-a/bRa was more than 10-fold
higher (P = 0.0199) in the medulla compared to the cor-
tex. The relative mRNA level of integrin-a7 (1.133) was
6.8-fold higher (P = 0.0233) in the cortex compared to
the medulla. Most genes in the FGF family, the integrin
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Table 4. The relative mRNA levels (mean ± SE) of the genes
differentially expressed between the kidney medulla and cortex of
lean dogs
GeneBank
Gene Name Number Medulla Cortex P value
CAD -11 L34056 1.057 ± 0.207 0.269 ± 0.153 0.0112
CAD -12 L34057 0.281 ± 0.035 0.092 ± 0.016 0.0203
N-cadherin X54315 0.088 ± 0.026 0.019 ± 0.008 0.0225
ALCAM L38608 0.213 ± 0.022 0.051 ± 0.027 0.0018
E-selectin M30640 0.031 ± 0.022 0.149 ± 0.014 0.0003
FGF-6 X63454 0.165 ± 0.026 0.056 ± 0.021 0.0083
FGF-7 M60828 0.019 ± 0.004 0.071 ± 0.023 0.0387
FGF-12 U66197 0.055 ± 0.015 0.017 ± 0.009 0.0403
FGF-14 U66200 0.243 ± 0.029 0.084 ± 0.061 0.0292
FGF-16 AB009391 0.095 ± 0.031 0.012 ± 0.007 0.0193
FGF-17 AB009249 0.177 ± 0.051 0.054 ± 0.013 0.0309
Cysteine-rich U28811 0.412 ± 0.092 0.113 ± 0.039 0.0124
FGF-R
FGF-R2 U11814 1.041 ± 0.308 0.300 ± 0.173 0.0403
FGF-R3 M58051 0.551 ± 0.064 0.135 ± 0.029 0.0005
FGF-R4 L03840 0.505 ± 0.123 0.158 ± 0.044 0.0191
CD6 U34625 1.485 ± 0.339 0.259 ± 0.125 0.0182
CD8a M12828 0.432 ± 0.056 0.122 ± 0.086 0.0118
ST2 D12763 0.237 ± 0.035 0.083 ± 0.032 0.0093
BCA-1 AF044197 0.032 ± 0.010 0.011 ± 0.001 0.0395
IP-10 X02530 0.404 ± 0.049 0.110 ± 0.045 0.0022
Fractalkine U91835 0.213 ± 0.036 0.096 ± 0.019 0.0149
GRO-c M36821 0.562 ± 0.104 0.119 ± 0.067 0.0059
CXCR-1 L19591 0.105 ± 0.037 0.024 ± 0.002 0.0376
IGF-I X56773 0.137 ± 0.026 0.047 ± 0.013 0.0119
LIF X13967 0.079 ± 0.017 0.018 ± 0.009 0.0128
Oncostatin M AH001516 0.358 ± 0.102 0.063 ± 0.024 0.0158
PDGF-A chain X03795 0.078 ± 0.023 0.023 ± 0.009 0.0348
SARP-1 AF017986 0.179 ± 0.031 0.092 ± 0.011 0.0201
G-CSF R M59818 0.206 ± 0.075 0.042 ± 0.012 0.0409
IFN-a/b Ra J03171 1.569 ± 0.544 0.143 ± 0.028 0.0199
MSP-R X70040 0.374 ± 0.073 0.147 ± 0.083 0.0435
PDGF-Rb M21616 0.383 ± 0.051 0.061 ± 0.017 0.0005
IGF binding P-7 L19182 0.506 ± 0.139 0.182 ± 0.051 0.0361
Integrin-a1 X68742 0.370 ± 0.067 0.057 ± 0.029 0.0026
Integrin-a2 M28249 0.490 ± 0.059 0.082 ± 0.034 0.0005
Integrin-a4 X16983 0.351 ± 0.070 0.171 ± 0.037 0.0105
Integrin-a5 X06256 0.125 ± 0.034 0.044 ± 0.009 0.0321
Integrin-a6 X53586 0.317 ± 0.070 0.037 ± 0.021 0.0043
Integrin-a7 AF072132 0.166 ± 0.046 1.133 ± 0.384 0.0233
Integrin-a9 L24158 0.370 ± 0.073 0.077 ± 0.037 0.0061
Integrin-aE L25851 0.349 ± 0.069 0.102 ± 0.026 0.0081
Integrin-aV M14648 0.381 ± 0.041 0.103 ± 0.022 0.0005
Integrin-b 1 X07979 0.567 ± 0.076 0.097 ± 0.048 0.0009
Integrin-b 3 M20311 0.735 ± 0.090 0.130 ± 0.020 0.0191
Integrin-b 5 X53002 0.376 ± 0.092 0.054 ± 0.016 0.0071
Integrin-b 6 M35198 0.502 ± 0.125 0.090 ± 0.055 0.0117
Integrin-b 7 S80335 0.793 ± 0.168 0.350 ± 0.138 0.0441
erbB3 M29368 0.119 ± 0.034 0.037 ± 0.004 0.0273
Activin RIB NM 004302 0.260 ± 0.059 0.695 ± 0.126 0.0105
BMP-8 M97016 1.154 ± 0.127 0.775 ± 0.104 0.0325
TGF-b2 M19154 0.039 ± 0.012 0.143 ± 0.045 0.0365
TGF-b RI AF054598 0.434 ± 0.256 1.637 ± 0.548 0.0471
Ephrin-A1 M57730 0.572 ± 0.193 0.069 ± 0.003 0.0205
Ephrin-A2 AJ007202 1.090 ± 0.397 0.170 ± 0.009 0.0299
Ephrin-A5 U26403 0.834 ± 0.207 0.211 ± 0.051 0.0135
Ephrin-B1 U09303 5.976 ± 2.467 1.635 ± 0.637 0.0404
EphA4 L36645 0.168 ± 0.055 0.049 ± 0.008 0.0396
EphB1 L40636 1.121 ± 0.345 0.229 ± 0.059 0.0236
EphB3 X75208 0.417 ± 0.123 0.068 ± 0.027 0.0151
EphB4 U07695 0.997 ± 0.308 0.184 ± 0.027 0.0196
IL-1b M15330 0.053 ± 0.003 0.021 ± 0.011 0.0141
IL-10 M57627 0.037 ± 0.006 0.121 ± 0.015 0.0011
IL-1ra M55646 0.061 ± 0.021 0.015 ± 0.003 0.0366
IL-2Ra X01057 0.025 ± 0.004 0.089 ± 0.025 0.0261
Table 4. continued.
GeneBank
Gene Name Number Medulla Cortex P value
IL-2Rb M26062 0.098 ± 0.009 0.574 ± 0.180 0.0129
IL-3Ra M74782 0.620 ± 0.041 0.155 ± 0.092 0.0018
IL-15Ra M96651 0.440 ± 0.125 0.147 ± 0.043 0.0352
IL-18R U43672 0.024 ± 0.009 0.075 ± 0.022 0.0413
GFRa1 U97144 0.834 ± 0.209 0.040 ± 0.010 0.0045
GFRa3 NM 001496 0.690 ± 0.148 0.295 ± 0.093 0.0322
Neuropilin-2 AF022860 0.431 ± 0.053 0.138 ± 0.051 0.0037
beta-NFG X52599 0.197 ± 0.029 0.097 ± 0.032 0.0324
Semaphorin F U52840 0.097 ± 0.035 0.024 ± 0.009 0.0473
TrkA M23102 0.094 ± 0.021 0.037 ± 0.011 0.0271
TrkB U12140 0.095 ± 0.016 0.036 ± 0.007 0.0081
GFR-5 L36149 0.172 ± 0.018 0.078 ± 0.016 0.0038
STRL33 U73529 0.034 ± 0.004 0.052 ± 0.008 0.0456
SPC4 M80482 0.048 ± 0.006 0.075 ± 0.009 0.0241
MMP-1 X05231 0.062 ± 0.015 0.152 ± 0.041 0.0435
April AF046888 0.445 ± 0.056 0.880 ± 0.019 0.0377
CD30L L09753 0.265 ± 0.080 0.075 ± 0.016 0.0302
DR-6 AF068868 0.082 ± 0.022 0.307 ± 0.072 0.0121
Osteoprotegerin U94332 0.019 ± 0.007 0.065 ± 0.018 0.0306
OX40L D90224 0.026 ± 0.011 0.217 ± 0.077 0.0244
TRAIL U57059 0.070 ± 0.010 0.031 ± 0.010 0.0176
Osteopontin J04765 0.112 ± 0.016 0.036 ± 0.005 0.0023
GM-CSF Ra X17648 0.066 ± 0.019 0.020 ± 0.003 0.0319
family, and the ephrin family were expressed to a greater
extent in the medulla compared to the cortex.
We also found that endothelin-2 was highly expressed
of the 375 genes in the kidney medulla as well as the
cortex, where the relative mRNA levels of endothelin-2
were 6.20 ± 1.48 (SE) and 5.75 ± 030, respectively. The
relative mRNA levels of endothelin-3 in the medulla and
the cortex were 0.77 ± 0.22 and 0.57 ± 0.30, respectively.
In contrast, the relative mRNA levels of endotheial nitric
oxide synthase (eNOS), inducible nitric oxide synthase
(iNOS), and neuronal nitric oxide synthase (nNOS) in
the medulla were 0.15 ± 0.05, 0.04 ± 0.01, and 0.09 ±
0.01, respectively. Their expressions in the cortex were
similar to those observed in the medulla.
DISCUSSION
In the present study, cDNA array analysis was used
to identity altered molecular pathways associated with
changes in renal function and structure in the early stages
of dietary-induced obesity in dogs. We utilized cDNA
membrane arrays containing 375 cytokine-related genes
to compare the gene expression profiles in the renal
medulla and cortex in lean and obese dogs. We focused
specifically on cytokine-related genes since our previous
studies suggested that accumulation of ECM and possi-
ble activation of inflammatory pathways may be involved
in the early renal pathophysiology found in obesity [9].
Only a few candidate genes have been investigated as
potential mediators of obesity-induced renal structural
and functional changes. The primary goal of the present
study was to examine changes in expression of a large
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number of cytokine genes that may be involved in me-
diating obesity renal changes using a targeted cytokine
gene array and examining cardiovascular and renal func-
tional changes in a dietary model of obesity that closely
mimics the changes observed in human obesity.
We have previously shown that dogs fed a high fat
diet have cardiovascular, renal, endocrine, and metabolic
changes that closely mimic those observed in obese hu-
mans. However, dog-specific gene arrays are not readily
available and very few candidate genes from dogs have
been sequenced. We therefore tested the hybridization of
dog RNA-derived cDNA versus human DNA sequences
immobilized on nylon membranes. Fortunately, this hu-
man array system worked well with dog kidney RNA as
evidenced by the following. First, we were able to observe
significant expression of most of the cytokine genes in
both the kidney medulla and cortex of dogs. This suggests
that the human cDNA probes on the array contained suf-
ficient sequence identity to canine homologues. Second,
there was a linear and quantitative response with a wide
dynamic range more than five to six orders of magni-
tude for detecting the expression of 375 cytokine-related
genes in the dog tissues. Third, all statistically significant
changes in renal gene expression profiles between lean
and obese dogs were interpretable and were closely re-
lated to certain functional pathways in relation to obe-
sity hypertension. Finally, using Northern blot analysis,
we found that human TGF-b1 cDNA probe could detect
TGF-b1 mRNA expression in dog tissues. Therefore, it
is likely that most of the human cytokine cDNA probes
on the array have substantial cross-reaction with dog cy-
tokine genes.
Assessing the cDNA membrane array results
The cDNA array technologies provide an effective
means to simultaneously monitor the expression of a
large number of genes in biologic systems. However,
problems associated with background noise, normaliza-
tion, and false positive results have caused substantial
concerns in the application of the cDNA microarray tech-
nologies [13, 14]. To ensure the interpretability of the
experimental results generated using cDNA array
technologies, certain minimum information should be
reported. In this study, we followed the Minimum Infor-
mation About a Microarry Experiment (MIAME) stan-
dards [15].
The high-density membrane array system used in the
present study not only gives a linear and quantitative
response with a wide dynamic range of five or six or-
ders of magnitude, but it also has the advantage of low
background noise as well as direct and more exact mea-
surements [13]. In order to further reduce background
noise, the background subtraction was performed locally
(taking the background around each gene spot) when do-
ing image analysis.
There were nine listed housekeeping genes in the array
membrane used. We found that some of the listed house-
keeping genes were not stable between the two groups.
For example, the signal intensity of b-actin in the renal
cortex of obese dogs was 40% higher than that observed
in lean dogs. Using a cDNA membrane array system,
Lyn et al [16] also found that the b-actin signal inten-
sity increased more than twofold in the myocardium after
ischemia compared to the control, while the signal inten-
sity of ribosomal protein S29 was very similar between
the two groups. The L19 mRNA signal did not differ in
obese and lean dogs and served as a stable internal house-
keeping gene to normalize signals of all the genes in each
set of arrays in the present study.
The next critical step was to determine whether
changes of gene expression were statistically significant.
The cDNA microarray data analysis system usually sets
up the thresholds of >twofold or >fourfold changes of
gene expression over the control in order to determine
differential gene expression [13, 14]. However, these high
thresholds may not allow detection of many expressed
genes that are physiologically relevant. In this study, the
data analysis was based upon the comparison of multiple
lean (N = 4) and obese dogs (N = 4). All statistically
significant changes in renal gene expression profiles
between lean and obese dogs were closely related to
certain functional pathways in relation to obesity hyper-
tension (Table 5). Future studies are needed to elucidate
the role of each these genes in mediating renal changes
associated with obesity and to extending these analyses
to earlier time points to identify candidates for regulatory
genes that show altered expression even before histologic
changes take place during the development of obesity
hypertension.
Identification of differentially expressed renal genes
related to possible functional pathways in
obesity hypertension
The magnitude of tubulointerstitial injury is an impor-
tant prognostic marker of renal outcomes in many forms
of renal diseases. Accumulation of ECM in the renal in-
terstitium and glomerulus is a characteristic pathologic
feature of kidney disease [17]. However, there are a few
studies examining the effects of obesity on renal ECM
formation, especially in the early stage before develop-
ment of diabetes mellitus. Table 2 indicates that after
only 10 weeks of a high fat diet there was a significant
up-regulation of TGF-b1 mRNA expression and down-
regulation of MMP-3 mRNA expression in renal medulla
of obese dogs, compared to lean dogs. TGF-b has been
identified as a key mediator of ECM synthesis and ac-
cumulation during the progression of renal disease [18].
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Table 5. Functional clustering of renal cytokine genes related to
obesity hypertension
Possible functional
pathways Alteration of the renal genes References
Sympathetic Up-regulation of FGF-14, GFR-a3, 21–24
activation endothelin-3, and STRL33
Inflammatory Up-regulation of ENA-78, P-selectin, 25–29
response and IL-13Ra2; down-regulation of
OSM-Rb and LIFR
Matrix formation Up-regulation of TGF-b1 and down- 16–19
regulation of MMP-3
Angiogenesis Up-regulation of VEGF, TGF-a, 30–34
TGF-b1, P-selection, and ephrin A1;
Down-regulation of MMP-3 and
TIMP-3
Endothelial Up-regulation of endothelin-3 and 35–37
dysfunction P-selectin
Attenuated actions Down-regulation of leptin receptor 38–40
of leptin and LIFR
Attenuated cell Down-regulation of FGF-1, FGF-3, 41–49
survival Integrin-a3, K cadherin, VCAM-1,
BCA-1, and MIP-1d
Abbreviations are: FGF, fibroblast growth factor; GFR-a3, glial cell line–
derived neurotrophic factor receptor-a3; ENA-78, epithelial cell–derived
neutrophil attractant-78; IL-13Ra2, interleukin-13 receptor-a2; OSM-Rb ,
oncostatin M receptor b ; LIFR, leukemia inhibitory factor receptor; TGF-
b1, transforming growth factor-b1; MMP-3, matix metalloproteinase-3;
VEGF-B, vascular endothelial growth factor-B; TIMP-3, tissue inhibitor of
metalloproteinase-3; VCAM-1, vascular cell adhesion molecule-1; BCA-1,
B-cell–attracting chemokine-1; MIP-1d, macrophage inflammatory protein-1d.
Among different TGF-b isoforms, TGF-b1 is the most
highly expressed within the kidney [18]. MMPs are en-
zymes that degrade ECM components. Uchio et al [19]
reported that decreased MMP activities caused abnor-
mal accumulation of ECM in the kidneys of hereditary
nephrotic mice. Studies have also shown important roles
of increased TGF-b1 and decreased MMP in renal dis-
ease [18, 19]. However, their roles in obesity-associated
renal disease are unknown. Further studies are needed to
determine if up-regulation of TGF-b1 mRNA expression
and down-regulation of MMP-3 mRNA expression in re-
nal medulla of obese dogs may contribute to increased
ECM formation obesity-induced renal injury.
Several observations suggest that increased renal sym-
pathetic activity is a major factor contributing to obesity
hypertension [5–8]. For example, bilateral renal denerva-
tion greatly attenuated sodium retention and hyperten-
sion in obese dogs fed a high fat diet for 5 weeks [20]. In
the present study, we found increased mRNA expressions
of FGF-14, GFR-a3, endothelin-3, and STRL33 in renal
medulla of obese dogs compared to lean dogs. FGF-14
is a neuro-isoform of fibroblast growth factor that is up-
regulated in the early stages of limb development when
innervation is taking place [21]. GFR-a3 is a receptor
component primarily related to artemin, a glial cell line–
derived neurotrophic factor that can function for sym-
pathetic neurone generation, survival, and growth [22].
Endothelin-3 is a neuro-isoform of endothelin that in-
fluences salt and water homeostasis through its multiple
effects on hormone system and sympathetic activation
[23]. Previous studies also indicate that sympathetic ac-
tivation enhances endothelin-3 release [23]. STRL33 is
an orphan receptor which also functions as chemokine
receptors in the nervous system [24]. Although the role
of each of these pathways in obesity hypertension is un-
known, the data from our study provide important clues
for further investigation of FGF-14, GFR-a3, endothelin-
3, and STRL33 in the renal structural and functional
changes associated with sympathetic activation in obesity
hypertension.
CONCLUSION
We found that expression of 11 and 13 genes changed
significantly in the renal medulla and the cortex of obese
dogs, respectively, relative to the lean dogs. Potential
functional pathways that may link these differentially
expressed genes to obesity hypertension are shown in
Table 5. These functional pathways include sympathetic
activation [21–24], inflammatory responses [25–29], ECM
formation [16–19], angiogenesis [30–34], endothelial dys-
function [35–37], attenuated actions of leptin [38–40],
and attenuated cell survival [41–49]. Functional cluster-
ing of genes identified as differentially expressed by using
cDNA membrane-arrays analysis further suggests that
the mechanisms of obesity hypertension and renal injury
are complex and multifactorial. These functional genomic
data will enhance the understanding of potential molecu-
lar links among obesity, hypertension, and abnormal kid-
ney structure and function. An interesting aspect of the
present studies is that many of the changes in gene expres-
sion were observed after only 10 weeks of a high fat diet,
before severe metabolic changes were observed, and with
only modest increases in blood pressure. Therefore, fur-
ther studies are needed to investigate the time course of
altered gene expression profile during the development
of obesity hypertension.
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